These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2663323

  • 1. Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate.
    Audran M, Clochon P, Etghen D, Mazieres B, Renier JC.
    Clin Rheumatol; 1989 Mar; 8(1):71-9. PubMed ID: 2663323
    [Abstract] [Full Text] [Related]

  • 2. Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone.
    Reginster JY, Jeugmans-Huynen AM, Albert A, Denis D, Deroisy R, Lecart MP, Fontaine MA, Collette J, Franchimont P.
    Bone; 1988 Mar; 9(6):349-54. PubMed ID: 3073800
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 6. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR, Ibbertson HK, Holdaway IM, Rutland M, King A, Dodd G, Wattie DJ.
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M.
    Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
    Adami S, Salvagno G, Guarrera G, Montesanti F, Garavelli S, Rosini S, Lo Cascio V.
    Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
    Delmas PD, Chapuy MC, Edouard C, Meunier PJ.
    Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247
    [Abstract] [Full Text] [Related]

  • 11. [Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone].
    Lecart MP, Jeugmans-Huynen AM, Albert A, Denis D, Deroisy R, Fontaine MA, Collette J, Reginster JY, Franchimont P.
    Rev Med Liege; 1988 Dec 15; 43(24):799-806. PubMed ID: 3227219
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug 15; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone treated with a five day course of oral tiludronate.
    Reginster JY, Lecart MP, Deroisy R, Ethgen D, Zegels B, Franchimont P.
    Ann Rheum Dis; 1993 Jan 15; 52(1):54-7. PubMed ID: 8427515
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH.
    Cochrane Database Syst Rev; 2017 Dec 01; 12(12):CD004956. PubMed ID: 29192423
    [Abstract] [Full Text] [Related]

  • 19. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S, Massie JD, Postlethwaite AE, Palmieri GM.
    Arch Intern Med; 1989 Feb 01; 149(2):401-3. PubMed ID: 2783843
    [Abstract] [Full Text] [Related]

  • 20. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R, Turchetti V, Righi G, Vattimo A.
    Minerva Med; 1982 Mar 03; 73(9):467-72. PubMed ID: 6801555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.